Archil Jaliashvili/LinkedIn
Oct 2, 2026, 12:02
Archil Jaliashvili: Exploring BHOC as a Complementary Oxygen-Delivery Strategy
Archil Jaliashvili, Co-Chief Executive Officer at GeoBio Pharm, Biotech Executive, Strategic Partner of BHOC and Precision Oxygen Therapeutics, shared a post on LinkedIn:
“Postpartum hemorrhage is where time, blood access and physiology collide.
Stopping the bleeding comes first.
But once severe blood loss develops, falling perfusion and oxygen-carrying capacity create a second problem: can effective tissue oxygen delivery be maintained until definitive care and donor blood are available?
That is the research context in which we are examining BHOC as a potential complementary oxygen-delivery bridge, not as a replacement for hemorrhage control or transfusion.”
Other posts featuring Archil Jaliashvili on Hemostasis Today.
-
Oct 2, 2026, 12:02Fahad Laghari: Flow Diversion for a Cavernous Internal Carotid Artery Aneurysm
-
Oct 2, 2026, 11:57Cornelia Elena Predoi: Peri-Interventional Prophylactic Plasma Transfusion in Anaesthesia and Critical Care
-
Oct 2, 2026, 11:41Daniel Pereira Monteiro: Why HbA1c Fails in Hemoglobinopathies – Modern Glycemic Monitoring and Therapeutic Approaches
-
Oct 2, 2026, 11:26Khaled Musallam: De-LIGHT Study Reveals Age-Related Multisystem Morbidity in β-Thalassemia
-
Oct 2, 2026, 11:20Chris Baugh: Modern ED Strategies for Antithrombotic-Associated Bleeding
-
Oct 2, 2026, 09:20Anticoagulants, Blood Thinners, or Antithrombotic Medications? – World Thrombosis Day
-
Oct 2, 2026, 06:00Susan Wickersham: Gradual Shift towards Autologous Blood Transfusion is a Current Trend
-
Oct 2, 2026, 05:54Shamee Shastry: When Every Cell Reacts – The Hunt for Rare Blood
-
Oct 2, 2026, 05:49David Mclntosh: Expanding Plasma Protein Therapies in Underserved Regions